Glycotope GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Glycotope GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013936
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Glycotope GmbH (Glycotope) is a biopharmaceutical company that develops immuno-oncology products for the treatment of various types of cancer. The company’s expression platform offers proprietary technologies such as Glycobody (GET) and GlycoExpress(GEX) that allows the glycosylation of antibodies & glycoproteins in human metabolism. These are also used to develop treatments for infertility and blood coagulation disorders. Its oncology pipeline products are used for various cancers including ovarian, breast, lung, head and neck, gastric, non-small cell lung cancer (NSCLC) and others. Glycotope’s non oncology pipeline products are used for in-vitro fertilization (IVF), Haemophilia and other indications. The company has offices at Berlin and Heidelberg. Glycotope is headquartered in Berlin, Germany.

Glycotope GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Glycotope GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Glycotope GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Glycotope GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Glycotope GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Glycotope GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Glycotope GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Glycotope GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Glycotope Raises US$76.3 Million In Venture Financing 11
Partnerships 12
Daiichi Sankyo and Glycotope Enter into Option Agreement 12
Licensing Agreements 13
Airway Therapeutics Enters into Licensing Agreement with Glycotope 13
Octapharma Enters into Licensing Agreement with Glycotope 14
Equity Offering 15
Glycotope to Raise USD90 Million in Private Placement of Shares 15
Asset Transactions 16
Celonic Acquires Bio-Manufacturing Facility from Glycotope 16
Glycotope GmbH – Key Competitors 17
Glycotope GmbH – Key Employees 18
Glycotope GmbH – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Apr 29, 2016: Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer 20
Jan 07, 2016: Glycotope names Paul G Higham as new Chief Executive Officer 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Glycotope GmbH, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Glycotope GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Glycotope GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Glycotope GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Glycotope GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Glycotope GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Glycotope GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Glycotope Raises US$76.3 Million In Venture Financing 11
Daiichi Sankyo and Glycotope Enter into Option Agreement 12
Airway Therapeutics Enters into Licensing Agreement with Glycotope 13
Octapharma Enters into Licensing Agreement with Glycotope 14
Glycotope to Raise USD90 Million in Private Placement of Shares 15
Celonic Acquires Bio-Manufacturing Facility from Glycotope 16
Glycotope GmbH, Key Competitors 17
Glycotope GmbH, Key Employees 18
Glycotope GmbH, Subsidiaries 19

★海外企業調査レポート[Glycotope GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marriott International Inc:企業のM&A・事業提携・投資動向
    Marriott International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marriott International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Transocean Ltd.:戦略・SWOT・企業財務分析
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Phoenix Petroleum Philippines Inc (PNX):企業の財務・戦略的SWOT分析
    Summary Phoenix Petroleum Philippines Inc (PNX) is an independent oil and gas company that distributes petroleum products and lubricants. The company provides automotive fuels, biodiesel, gasoline and aviation fuels, among others. It offers services such as trading of refined petroleum products and …
  • Cabela’S Inc:企業の戦略・SWOT・財務分析
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Towngas China Co Ltd (1083):石油・ガス:M&Aディール及び事業提携情報
    Summary Towngas China Co Ltd (Towngas China), a subsidiary of The Hong Kong and China Gas Co Ltd is an oil and gas company that distributes natural gas. The company's business activities include sale and distribution of pipeline gas, gas pipe network construction, operating urban pipeline gas networ …
  • AMAG Pharmaceuticals Inc (AMAG):医療機器:M&Aディール及び事業提携情報
    Summary AMAG Pharmaceuticals Inc (AMAG) develops and commercializes specialty pharmaceutical products with focus on maternal health, anemia management and cancer supportive care. It develops and markets products used to reduce the risk of preterm birth in women with a single baby who have a history …
  • Randall & Quilter Investment Holdings Ltd.:企業のM&A・事業提携・投資動向
    Randall & Quilter Investment Holdings Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Randall & Quilter Investment Holdings Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析
    Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ck Hutchison Holdings Ltd
    Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ARISCOM Compagnia di Assicurazioni S.p.A.:企業の戦略・SWOT・財務情報
    ARISCOM Compagnia di Assicurazioni S.p.A. - Strategy, SWOT and Corporate Finance Report Summary ARISCOM Compagnia di Assicurazioni S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Texas Children’s Hospital:企業の戦略的SWOT分析
    Texas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Yellowstone Valley Electric Cooperative, Inc.:発電所・企業SWOT分析
    Yellowstone Valley Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • MimiVax LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary MimiVax LLC (MimiVax) is a pharmaceutical company that discovers and develops immunotherapeutic vaccines and targeted therapies for the treatment of cancer. The company’s lead candidate is SurVaxM. Its SurVaxM is a cancer vaccine that stimulates a potent immune response and the survivin mole …
  • KAMCO Investment Company K.S.C.P. (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Company K.S.C.P. (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • CIMB Private Banking:企業の戦略・SWOT・財務情報
    CIMB Private Banking - Strategy, SWOT and Corporate Finance Report Summary CIMB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Primark Stores Ltd:戦略・SWOT・企業財務分析
    Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Takashimaya Company, Limited:企業の戦略・SWOT・財務分析
    Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Pavmed Inc (PAVM):医療機器:M&Aディール及び事業提携情報
    Summary Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; P …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆